skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Exploring the impact of pharmacist comprehensive annual care plans on perceived quality of chronic illness care by patients in Alberta, Canada

Canadian pharmacists journal, 2021-09, Vol.154 (5), p.331-341 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) 2021. ;The Author(s) 2021 2021 Canadian Pharmacists Association ;ISSN: 1715-1635 ;EISSN: 1913-701X ;DOI: 10.1177/17151635211020340 ;PMID: 34484483

Full text available

Citations Cited by
  • Title:
    Exploring the impact of pharmacist comprehensive annual care plans on perceived quality of chronic illness care by patients in Alberta, Canada
  • Author: Necyk, Candace ; Johnson, Jeffrey A. ; Tsuyuki, Ross T. ; Eurich, Dean T.
  • Subjects: Chronic illnesses ; Drug stores ; Original Research ; Perceptions ; Pharmacists ; Questionnaires
  • Is Part Of: Canadian pharmacists journal, 2021-09, Vol.154 (5), p.331-341
  • Description: Background: In 2012, the Government of Alberta introduced a funding program to remunerate pharmacists to develop a comprehensive annual care plan (CACP) for patients with complex needs. The objective of this study is to explore patients’ perceptions of the care they received through the pharmacist CACP program in Alberta. Methods: We invited 3442 patients who received a pharmacist-billed CACP within the previous 3 months and 6888 matched controls across Alberta to complete an online questionnaire. The questionnaire consisted of the short version Patient Assessment of Chronic Illness Care (PACIC-11), with 3 additional pharmacy-specific assessment questions added. Additional questions related to health status and demographics were also included. Results: Overall, most patients indicated a low level of chronic illness care by pharmacists, with few differences noted between CACP patients and non-CACP controls. Of note, controls reported higher quality of care for 5 domains within the adapted PACIC-like tool compared with CACP patients (p < 0.05 for all). Interestingly, only 79 (44%) of CACP patients reported that they had received a CACP, whereas only 192 (66%) of control patients reported that they did not receive a care plan. In a sensitivity analysis including only these respondents, individuals who received a CACP perceived a significantly higher quality of chronic illness care across all PACIC domains. Conclusion: Overall, chronic illness care incentivized by the pharmacist CACP program in Alberta is perceived to be moderate to low. When limited to respondents who explicitly recognized receiving the service or not, the perceptions of quality of care were more positive. This suggests that better implementation of CACP by pharmacists may be associated with improved quality of care and that some redesign is needed to engage patients more. Can Pharm J (Ott) 2021;154:xx-xx.
  • Publisher: Los Angeles, CA: SAGE Publications
  • Language: English;French
  • Identifier: ISSN: 1715-1635
    EISSN: 1913-701X
    DOI: 10.1177/17151635211020340
    PMID: 34484483
  • Source: Sage Journals GOLD Open Access 2024
    Open Access: PubMed Central

Searching Remote Databases, Please Wait